1. Home
  2. Labeler Index
  3. Marlex Pharmaceuticals Inc
  4. 10135-647
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 10135-647 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

gabapentin 600mg 100s

gabapentin 600mg 100s

Gabapentin is a medication that comes in USP tablets and is only available through prescription. This bottle contains 100 tablets of Gabapentin. The bottle comes inside protective packaging that resists child tampering. The medication is manufactured by Mariex Pharmaceuticals, Inc. Unfortunately, the dosage and usage instructions are not available as they were not included in the text.*

gabapentin 600mg 500s

gabapentin 600mg 500s

This is the label of a Gabapentin medicine box manufactured by MarLex. The medicine comes in tablet form and is only available via a prescription. Each bottle of Gabapentin contains 500 tablets and each tablet consists of 00 Gatapntin, USP. The drug should be taken as prescribed by a physician as an analgesic to control pain. The company is based in New York.*

gabapentin 800mg 100s

gabapentin 800mg 100s

This is a medication description for Gabapentin Tablets, which are used to treat seizures and nerve pain. It comes in a 100 tablet bottle and each tablet contains 50mg of Gabapentin USP. The recommended starting dosage is unclear but appears to be related to the patient's individual circumstances. The medication is manufactured by Marex Pharmaceuticals and distributed by them. The address provided is N St, E 19720.*

gabapentin 800mg 500s

gabapentin 800mg 500s

This text is a product label for Gabapentin tablets, USP, containing 500 tablets. It also includes the NDC number, dosage instructions, and manufacturer information.*

Creatinine clearance (CLCr) is difficult to measure in outpatients. In patients with stable renal function, creatinine clearance can be reasonably well estimated using the equation of Cockcroft and Gault: - gabapentin tablets 01

Creatinine clearance (CLCr) is difficult to measure in outpatients. In patients with stable renal function, creatinine clearance can be reasonably well estimated using the equation of Cockcroft and Gault: - gabapentin tablets 01

The structural formual for Gabapentin, USP is a white to off-white crystalline solid with a pKa1 of 4.72±0.10 and a pKa2 of 10.27±0.29. It is freely soluble in water and both basic and acidic aqueous solutions. The log of the partition coefficient is -1.083±0.235 at 25°C temperature. - gabapentin tablets 02

The structural formual for Gabapentin, USP is a white to off-white crystalline solid with a pKa1 of 4.72±0.10 and a pKa2 of 10.27±0.29. It is freely soluble in water and both basic and acidic aqueous solutions. The log of the partition coefficient is -1.083±0.235 at 25°C temperature. - gabapentin tablets 02

In two of the three controlled studies, more than one dose of gabapentin was used. Within each study, the results did not show a consistently increased response to dose. However, looking across studies, a trend toward increasing efficacy with increasing dose is evident (see Figure 4). - gabapentin tablets 03

In two of the three controlled studies, more than one dose of gabapentin was used. Within each study, the results did not show a consistently increased response to dose. However, looking across studies, a trend toward increasing efficacy with increasing dose is evident (see Figure 4). - gabapentin tablets 03

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.